Navigation Links
The Effect Of Pain Relievers In Treating Kids With Migraine Questioned

Migraine headaches, usually an inherited disorder, are common in children with frequency increasing in adolescence, // according to researchers. The pain relievers ibuprofen and acetaminophen are safe and effective for treating migraine headaches in children and adolescents according to new guidelines published by the American Academy of Neurology and the Child Neurology Society.

Researchers evaluated over 166 articles and abstracts on children ages 3 to 18 to determine the best treatment for migraines in these patients. Results showed acetaminophen and ibuprofen, both over-the-counter pain relievers, are safe and effective to use as a migraine treatment in children and adolescents. The nasal spray sumatriptan was found safe and effective for adolescents to use for migraines. However, the study showed insufficient evidence to recommend preventive treatments such as topiramate, amitriptyline, or divalproex sodium.

Thus researchers say they are confident that pharmacological headache treatments given to adults are also safe and effective for children.
'"/>




Page: 1

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Inhaled Steroids Safe & Effective for Children with Asthma
3. Acupuncture May Help Chemotherapy Side Effects
4. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
5. Fluoride Found Effective in Osteoporosis
6. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
7. Implantable Contact Lens Found Safe and Effective
8. Effective And Economical Agent For Anthrax
9. Stem Cell Transplants May Be Effective For MS Patients
10. Chemotherapy Pill Has Fewer Side Effects Than IV
11. Effect of Osteosarcoma predicted by scans
Post Your Comments:
(Date:7/9/2008)...aleate (Acepromazine) is on extended backorder fro...nd this preparation into Gourmeds™ (chewable...nsion in the most frequently prescribed strengths....r veterinary use only. , ... -- Commonly prescribed for both cats and dogs, A...
(Date:7/9/2008)...he Maltese healthcare system,will be the focus of ... the,world learn how the island nation,s healthcar...odel for the European Union to follow. Affiliated,...um to discuss the future,of healthcare and informa...tions., Four recognized experts in healthcare and...
(Date:7/9/2008)...mpany Provides Interoperable EHR Solution Capa...ROLLTON, Ga., July 9 /PRNewswire/ -- Greenway Medi...e National Health IT Week,s Capitol Hill,Technolog...ne 9, 2008. The,showcase marked one of the healthc...ime demonstrations of ambulatory software provider...
(Date:7/9/2008)...r Summer, LAUREL, Miss., July 9 /PRNewswire/ -- W...popular parking place for TV-watchers, Sanderson F...mer program to encourage,families to get healthy b..., Studies show that over the course of a year, ch... school or participating in any activity other,tha...
Breaking Medicine News(10 mins):Health News: Wedgewood Pharmacy Responds to Acepromazine Maleate Drug Shortage 2Health News:ACS Forum to Showcase Innovative Healthcare Model for European Union 2Health News:ACS Forum to Showcase Innovative Healthcare Model for European Union 3Health News:Greenway Medical Technologies Leads Ambulatory Interoperability Exchange 2Health News:Greenway Medical Technologies Leads Ambulatory Interoperability Exchange 3Health News:Greenway Medical Technologies Leads Ambulatory Interoperability Exchange 4Health News:Sanderson Farms Launches New Summer Program Encouraging Families to Get Healthy 2
...creased by 12% in six years, according to the char...are now diagnosed with the disease, 3,000 of those...elanomas in men is that they tend to occur more co...they are often on the lower leg and more noticeabl...
...nancy can increase a mother's risk of having a hyp...ere very anxious// in the last three months of pre.... Lead researcher Professor Vivette Glover, of Im... only applied to women who had extreme anxiety, an...
...n somebody is likely to have an epileptic seizure....enly and without warning and can lead to disabilit... la Pitie-Salpetriere, Paris, believe it may be po...res by carrying out an electroencephalogram (EEG)....
...than 100 years. And while most of the popular reme... the use of aspirin has increased. This powerful p...nt blood clots, and even reduce the risk of heart ...35 years since aspirin's potent anti-clotting effe...
Other Medicine News:
(Date:7/8/2008)...- McGraw-Hill Professional, a leading,global provi...d medical,communities, today announced the additio...its comprehensive online pharmacy education,resour... ). Through an alliance with,Doctor Evidence, deve...ical,studies, AccessPharmacy now provides in-conte...
(Date:7/7/2008)... Includes ANA598 and ANA773 Acting via In... Conference Call Today at 2:00 PM... Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS ) ann...ation of the Toll-Like Receptor-7 (TLR7) mechanism...n preclinical pharmacology testing,and the results...
(Date:7/7/2008)...-- OrbusNeich today announced that data,presented ...e Society of,Interventional Cardiology demonstrate... outcomes when compared to drug-eluting stents., ...principal,investigator and a professor with the Fe...ology, Department of Clinical Medicine and Cardiov...
(Date:7/6/2008)...ing Authorization Application currently ...uly 7 /- Cell Therapeutics,...the publication of results from its,randomized pha...glumex,CT-2103) with gemcitabine or vinorelbine f...tients with previously untreated non-small cell,lu...
Breaking Medicine Technology:McGraw-Hill Professional Launches Drug Effectiveness Resource on AccessPharmacy 2Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 2Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 3Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 4Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 5Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 2Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 4Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 5APIC launches first national C difficile prevalence study 14826 1APIC launches first national C difficile prevalence study 14826 2Cato Study Finds Iran a Surprising Model for Kidney Markets 14823 1Cato Study Finds Iran a Surprising Model for Kidney Markets 14823 2NanoBio Corporation Completes Interim Analysis of Phase 2 Clinical Trial in Onychomycosis 1573 1NanoBio Corporation Completes Interim Analysis of Phase 2 Clinical Trial in Onychomycosis 1573 2Subterfuge counter surveillance and assassination 3A The bodys fight with cervical cancer 2560 1Subterfuge counter surveillance and assassination 3A The bodys fight with cervical cancer 2560 2
...BOULDER, Colo.--(BUSINESS WIRE)--Jul 5, 2007 - Arr...hat its Chief Executive Officer,Robert E. Conway,...rowth Conference on July 10 in New York City. The ... through a webcast on the,Array BioPharma website....ng Growth Conference,Presenter: Robert E. Co...
... REHOVOT, Israel and NORTH BRUNSWICK, New Jersey, ...nomics Ltd , a leading microRNA,company, announced...esident, will present at CE Unterberg, Towbin Emer...uly 10, at 11:00 am EST at,the Mandarin Oriental H...esentation will be available on,the "Investors" se...
Other Medicine Technology:Rosetta Genomics to Webcast Presentation at CE Unterberg, Towbin,Emerging Growth Opportunities Conference 2
The BARDEX I.C. Catheter represents Bard's newest technology in providing protection against NUTI.
Used to provide bladder drainage by percutaneous placement of a Malecot catheter. Supplied sterile in peel-open packages. Intended for one-time use.
Surgisis ES is designed to provide enhanced strength for intraoperative applications. Supplied sterile in peel-open packages. Intended for single patient, one-time use.
Stratasis Urethral Sling is intended for implantation to reinforce soft tissues where weakness exists. Supplied sterile in peel-open packages. Intended for one-time use.
Medicine Products: